Digital innovation is transforming how Alzheimer’s disease is detected and monitored in clinical trials. Together, Medidata Solutions and Cogstate are advancing this process through a unified CNS solution that pairs scientific expertise with robust eCOA tools to elevate data quality and rater experience. Learn more about how these science-backed, technology-enabled services are setting a new benchmark for Alzheimer’s disease trial success – meet with our teams during CTAD 2025 in San Diego! Schedule a meeting here: https://lnkd.in/g65dbM65
